Issue 5, 2024

Metabolomic approaches to dissect dysregulated metabolism in the progression of pre-diabetes to T2DM

Abstract

Many individuals with pre-diabetes eventually develop diabetes. Therefore, profiling of prediabetic metabolic disorders may be an effective targeted preventive measure. We aimed to elucidate the metabolic mechanism of progression of pre-diabetes to type 2 diabetes mellitus (T2DM) from a metabolic perspective. Four sets of plasma samples (20 subjects per group) collected according to fasting blood glucose (FBG) concentration were subjected to metabolomic analysis. An integrative approach of metabolome and WGCNA was employed to explore candidate metabolites. Compared with the healthy group (FBG < 5.6 mmol L−1), 113 metabolites were differentially expressed in the early stage of pre-diabetes (5.6 mmol L−1 ⩽ FBG < 6.1 mmol L−1), 237 in the late stage of pre-diabetes (6.1 mmol L−1 ⩽ FBG < 7.0 mmol L−1), and 245 in the T2DM group (FBG [gt-or-equal] 7.0 mmol L−1). A total of 27 differentially expressed metabolites (DEMs) were shared in all comparisons. Among them, L-norleucine was downregulated, whereas ethionamide, oxidized glutathione, 5-methylcytosine, and alpha-D-glucopyranoside beta-D-fructofuranosyl were increased with the rising levels of FBG. Surprisingly, 15 (11 lyso-phosphatidylcholines, L-norleucine, oxidized glutathione, arachidonic acid, and 5-oxoproline) of the 27 DEMs were ferroptosis-associated metabolites. WGCNA clustered all metabolites into 8 modules and the pathway enrichment analysis of DEMs showed a significant annotation to the insulin resistance-related pathway. Integrated analysis of DEMs, ROC and WGCNA modules determined 12 potential biomarkers for pre-diabetes and T2DM, including L-norleucine, 8 of which were L-arginine or its metabolites. L-Norleucine and L-arginine could serve as biomarkers for pre-diabetes. The inventory of metabolites provided by our plasma metabolome offers insights into T2DM physiology metabolism.

Graphical abstract: Metabolomic approaches to dissect dysregulated metabolism in the progression of pre-diabetes to T2DM

Supplementary files

Article information

Article type
Research Article
Submitted
19 Jul 2023
Accepted
01 Feb 2024
First published
30 Apr 2024
This article is Open Access
Creative Commons BY-NC license

Mol. Omics, 2024,20, 333-347

Metabolomic approaches to dissect dysregulated metabolism in the progression of pre-diabetes to T2DM

W. Ji, X. Xie, G. Bai, Y. He, L. Li, L. Zhang and D. Qiang, Mol. Omics, 2024, 20, 333 DOI: 10.1039/D3MO00130J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements